W H Kaesemeyer, MD is an independent research cardiologist whose current focus is preventing the activation of the NLRP3 inflammasome in the treatment of cardiovascular diseases, all as an extrapolation of his work on the cause and prevention of nitroglycerin tolerance. He has practiced for 28 years as a hypertension specialist who is board certified in internal medicine. This followed 4 years of medical school (MD 1978 Wake Forest University, Winston-Salem, NC) and 4 years of residency training that included a year as a chief resident, all of which followed initially working as a pharmaceutical chemist. He has been the principal investigator on 20 clinical trials of hypertension, lipids and heart failure medications. He is an author or co-author of over 35 publications and the inventor of 5 patents involving nitric oxide, nitroglycerin tolerance and statin nitric oxide pleiotropy

NOVEL FORMULATION OF IV NITROGLYCERIN (GTN) FOR TOLERANCE-FREE

Dr. Sahu is an Associate Professor in the Department of Pharmacology and Toxicology at Wright State University, Dayton, OH. His research is focused on determining the significance and mechanisms of prooxidative stressors-generated oxidized lipid mediators in impacting cancer growth and the efficacy of therapeutic agents. He has given invited talks to various national and international scientific organizations, published several peer-reviewed papers, and serves as an editorial board member, academic editor, and ad hoc reviewer of several scientific journals.

Impact of simultaneous exposure to an environmental carcinogen and pollutant on skin.

Dr.Maria Dalamagka currently works at the Department of Anesthesia, General University Hospital of Larissa. Maria does research in acupuncture and Anaesthetics. She is PhD medicine , doctor of pain , MD. Editorial board member :Scifed Journal, Pain Medicine and Management, Enliven, Cient Periodique, Journal of Pain Management and Medicine _Longdom, Anesthesia &Pain Research _Scivision, GJNFS, Journal if Pain and Relief. Speaker and organizing committee to conferences as:Pain Research and Management Zurich 2018, 5th international conference Pain Research &Management London 2017, and Vancouver , Canada 2016, Word congress on Pain Medicine and Management Singapore 2019, International Conference on Alzheimers &Neurodegenerative desease Madrid , Spain 2018, scientific federation speaker

Autism and General Anaesthesia for Dental Care

Dr R K Maheshwari, Professor, (Ex-Head), Pharmacy Department, S.G.S.I.T.S., Indore, India .Dr. R.K.Maheshwari,is presently working as Professor, Department of Pharmacy, S.G.S.I.T.S., Indore, India. M Pharm Projects Guided – More than 75,PhD (Guide/Coguide) – 02 PhD awarded, 01 Pursuing Published Research Papers – More than 200 ,Research Papers Presented in Conferences etc. – More than 150,Expert Lectures Delivered in India - More than 300.

novel concept of solubilization giving eco-friendly suggestions

A practicing physician in the field of healthcare in the state of Kerala in India for the last 35 years and very much interested in basic research. My interest is spread across the fever, inflammation and back pain. I am a writer. I already printed and published Ten books on these subjects. I wrote hundreds of articles in various magazines. After scientific studies, we have developed 8000 affirmative cross checking questions. It can explain all queries related to fever. After scientific studies we have developed 8000 affirmative cross checking questions. It can explain all queries related with fever. My 10 articles published in various journals.

Paracetamol is the most unscientific and dangerous drug for fever. Anyone can create a fever within hours using antipyretic objects.

Dr. Shyamapada Mandal is Professor and Head of the Department of Zoology, and Dean(Science), University of Gour Banga, India. He is working on infectious diseases, probiotics, andgenomics and bioinformatics research. He did pre-PhD, PhD, and post-PhD research under theguidance of Professor Nishith Kumar Pal at the Calcutta School of Tropical Medicine, India. Hehas published 130 articles with eight book chapters. He is life member of IAMM and IASR,India, and fellow member of SASS, India. Eight national academic and research awards havebeen conferred to him. He has guided 58 post graduate students; supervised four MPhil and six PhD students, and supervising four PhD students. Professor Mandal is among the world’s top 2% scientists as per the survey of the Stanford University, published in PLOS (Public Library of Science) Biology (October, 2020). He is featured in the top 2% world scientists list for second, third and fourth consecutive times as published by the Stanford University-Elsevier BV (October, 2021, October, 2022 and October, 2023).

Anti-Nipah virus activity of neoandrographolide from Andrographis paniculata by in silico methods

Highly skilled business developer with a knack for swiftly rising to managerial positions in the pharmaceutical sector. Renowned for crafting impactful partnerships, rejuvenating brands, and orchestrating corporate turnarounds. A serial entrepreneur with a flair for identifying and seizing emerging market opportunities, demonstrated through successful ventures in cryptocurrency, advertising, and international e-commerce. Passionate about driving business growth through strategic innovation and dynamic leadership.

BIO PHARMACEUTICS AND BIOLOGIC DRUGS

Dr. Abir Goswami, born in 1992 in West Bengal, India, completed his undergraduate studies at the University of Calcutta in 2012. He earned a master’s degree in chemistry from IIT Guwahati in 2014. He completed a Ph.D. in catalytic off-equilibrium molecular machines at the University of Siegen (Germany) under Prof. em. Dr. Michael Schmittel in 2020. Currently, he is working with Prof. Takuzo Aida at Riken, focusing on fluorinated macrocyclic molecules for drug delivery and PTFE adhesive materials, aiming to unravel the mysterious effect of fluorine in chemistry and biology.

Fluorous Crown Ether as a Fast Cell Permeating Agent for Direct Delivery

Dr. Rudra Pratap Singh Rajput has completed his B.Pharm form CSVTU, Bhilai (Chhattisgarh) in 2012 then moved towards Maharashtra State to complete his M.Pharm in 2014 from Pune University, Pune. Further the Doctoral degree Ph.D was awarded by JSSAHER, Mysuru (Karnataka) in 2018. He has started his academic carrier as Assistant Professor from Jeypore College of Pharmacy, Odisha in Aug, 2018 and continued in Columbia institute of Pharmacy, Raipur (Chhattisgarh) since 29th April, 2019 to 17th Feb, 2023. Further He switched to Royal College of Pharmacy, Raipur (Chhattisgarh) on 18th Feb, 2023 and continuing till date. He has supervised 15 degree and 10 post graduation students to accomplish project dissertation work. At present 4 research scholars are pursuing their PhD under his supervision. He has more than 33 publication in SCI(E) indexed reputed journals. He also received an international travel grant from ICMR, New Delhi to present his work on international platform. He has more than 300 actively participatation in various national and international conferences. Also, he has organized two government bodies sponsored DBT, New Delhi and AERB, Mumbai national conferences for the students, researchers and academicians.

Formulation, Characterization and Evaluation: Micellar Loaded Complex of Cuminum Cyminum to Treat Causing Disease of Respiratory infection

Douglas Amante is a global businessman and researcher believing that the future of health information technology will be the integration of electronic health record and artificial general intelligence for improved healthcare delivery, with the focus shifting from data to choices based on artificial general intelligence's role in health data analytics. Otherwise, it would be required to spend time reconciling innovation and patient rights with medical ethics

Revolutionizing Healthcare: EHR and AGI Integration for Enhanced Patient Outcomes

Motivated second-year Bachelor of Biotechnology student with a strong academic background, having completed one year at the University of Technology Sydney (UTS) and currently enrolled at the University of Adelaide. Proficient in molecular biology and genetic engineering, I possess practical laboratory skills and a solid foundation in biotechnological principles. Committed to ethical considerations in science, I am eager to contribute to impactful research projects and collaborative initiatives. Seeking opportunities to apply my knowledge, enhance my skills, and make meaningful contributions to the evolving field of biotechnology. Current student looking to join the workforce to gain real-world experience. Ability to complete tasks on time in both individual and team settings. Dependable and reliable, ready to learn and grow with your organisation

3D Printing in medicine: Technology overview and Drug Delivery applications

Dr. Evangelia Michail Michailidou Consultant Anesthesiologist -Intensivist at Hippocrates' General Hospital of Thessaloniki - Hellenic NHS - Life and Leadership Coach Office Administrator at the department of secretariat at Ηippocratio hospital of Thessaloniki from 2005 until 2010/Εmployee at the payroll department of fourth health region. Degree in Organization and Business administration.

Chikezie Kennedy Kalu’s field of research is Technology and Innovation Management. He is from Nigeria and has a B.Eng. in Electronics Engineering from The University of Nigeria Nsukka; Nigeria (UNN) and a Masters (with Distinction) in Communication Engineering from The University of Manchester, UK. Chikezie has presented his works at a good number of international conferences and he was also awarded the International Best Researcher in Management Science and Engineering at the Asia Research Awards (International Congress for Research Excellence 2024) in India, in March 2024.

Analysis of COVID-19 Vaccinations and Symptom Mapping Diagnostic Technique for Viral Diseases: Using Data Analytics, Machine Learning and Artificial Intelligence